GOV.UK
Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Drug and device alerts
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Blood regulation and safety
- Marketing authorisations and licensing guidance
- Patient information leaflets and summaries of product characteristics
- Drug Analysis Prints (DAPs)
- Public assessment reports
- Medical devices regulation and safety
- Contact MHRA
- All MHRA services and information
What the Medicines and Healthcare products Regulatory Agency is doing
5 September 2018 — News story
Change in the classification of certain glucosamine products
Products containing doses equal to or greater than 1178mg/day of base glucosamine will now be considered to be medicines.
20 September 2018 — News story
Voluntary recall of USA-manufactured homeopathic products: check for affected products
Certain batches of four homeopathic products manufactured in the USA have been voluntarily recalled due to possible microbial contamination.
24 September 2018 — News story
Improving how we collect and document consent
The Medicines and Healthcare products Regulatory Agency (MHRA) and the Health Research Authority (HRA) have published a joint statement on seeking and documenting consent using electronic methods (eConsent).
17 August 2018 — Collection
Marketing authorisations: lists of granted licences
Marketing authorisations (MAs) granted since January 2014.
17 August 2018 — Collection
Parallel import licences: lists of approved products
Parallel import (PLPI) licences granted since January 2014.
Latest from the Medicines and Healthcare products Regulatory Agency
- Valproate Pregnancy Prevention Programme: actions required now from GPs, specialists, and dispensers
- Xofigo▼ (radium-223-dichloride): new restrictions on use due to increased risk of fracture and trend for increased mortality seen in clinical trial
- Daclizumab beta (Zinbryta▼): risk of immune-mediated encephalitis – some cases several months after stopping treatment
Subscriptions
Subscribe to feed
What the Medicines and Healthcare products Regulatory Agency does
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Our announcements
Our publications
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
Corporate information
Jobs and contracts